What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...

> KRAS-gene variant is a biomarker of poor survival and worse response to treatment for patients with ovarian cancer. Release > Researchers have found pharmacogenetic and pharmacokinetic biomarker for ...

An anti-cancer drug that suppresses the immune system is the first drug that has been proved to alleviate the most devastating effects of scleroderma, a disease of the connecting tissues and lungs.